Interventional Cardiovascular Implant Simulation Software Device News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FEops today announced that it received De Novo authorization from the U.S. Food and Drug Administration (FDA) for FEops HEARTguide pre-operative planning of left atrial appendage occlusion with the

United statesUnited kingdomBritish columbiaKostenloser wertpapierhandelPeter mortierFeops heartguideFeops heartguide laaoInterventional cardiovascular implant simulation software deviceEuropean innovation councilEuropean unionDrug administrationBoston scientificVancouver general hospitalAmplatzer amuletOperator numberCapricorn partners